Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

28.67
+2.107.90%
Post-market: 28.940.2700+0.94%19:40 EDT
Volume:836.38K
Turnover:23.54M
Market Cap:2.03B
PE:-14.19
High:28.74
Open:26.97
Low:26.77
Close:26.57
52wk High:29.75
52wk Low:13.60
Shares:70.96M
Float Shares:66.05M
Volume Ratio:1.51
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0200
EPS(LYR):-1.0800
ROE:-72.31%
ROA:-24.14%
PB:25.31
PE(LYR):-26.55

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Seagate, nCino, Zymeworks

Reuters
·
Apr 01

Zymeworks Appoints Kristin Stafford CFO

MT Newswires Live
·
Apr 01

Zymeworks appoints Kristin Stafford as CFO effective April 1, 2026

Reuters
·
Apr 01

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

THOMSON REUTERS
·
Apr 01

BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar

Reuters
·
Mar 30

Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating

TIPRANKS
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike

Reuters
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Energy shares, miners, Sysco

Reuters
·
Mar 30

Zymeworks says FDA grants Fast Track designation for ovarian cancer drug ZW191

Reuters
·
Mar 30

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FrΑ-Targeting Antibody-Drug Conjugate

THOMSON REUTERS
·
Mar 30

Is New ZW191 and Pan-RAS ADC Data Acceptance Shifting The Investment Case For Zymeworks (ZYME)?

Simply Wall St.
·
Mar 30

A Look At Zymeworks (ZYME) Valuation As New AACR ADC Data Advances Its Cancer Pipeline

Simply Wall St.
·
Mar 27

Zymeworks to Present at Needham Virtual Healthcare Conference and Bloom Burton Healthcare Investor Conference

Reuters
·
Mar 24

Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting

TIPRANKS
·
Mar 18

Zymeworks partner Jazz to present four zanidatamab abstracts at AACR annual meeting

Reuters
·
Mar 18

Press Release: Zymeworks Announces Presentations for Ziihera(R) (zanidatamab-hrii) at 2026 AACR Annual Meeting

Dow Jones
·
Mar 18

Zymeworks to present ZW191 Phase 1 data and novel pan-RAS ADC platform at AACR Annual Meeting

Reuters
·
Mar 18

Analysts’ Top Healthcare Picks: GeneDx Holdings (WGS), Zymeworks (ZYME)

TIPRANKS
·
Mar 12

Zymeworks Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Mar 10

Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook

TIPRANKS
·
Mar 09